Reddit Posts
NTLA Deep Dive: Market Mispricing After Flawless Phase 3 CRISPR Data Published in NEJM Today - 35-40% short interest
NTLA Deep Dive: Why Todayβs Flawless Phase 3 CRISPR Data in NEJM Creates a Massive Valuation Disconnect
NTLA Deep Dive: Why Todayβs Flawless Phase 3 CRISPR Data in NEJM Changes Everything (And Why the 39% Short Interest is Mispriced
COMPLETE DD ON TENAYA THERAPEUTICS ($TNYA)! I collected all of their SEC Filings, their clinical trial results, their insider trading, their institutional ownership, their board of directors, their interview transcripts, and their CEO Faraz Aliβs full history and had Claude Ai do a full analysis!
SpaceX IPO Might Make Virgin Galactic ($SPCE) The Hottest Meme Stock of Summer
SpaceX IPO Might Make Virgin Galactic ($SPCE) The Hottest Meme Stock of Summer
RDDT is the most undervalued social media stock.
HMR Has the Same Squeeze DNA as GameStop - But With a Business That Actually Works (fyi i love how Cohen is running it now - Increasing Book Value & Cash)
10x Stocks: The DNA of Multibaggers
$GMEX β 36% SI on float, ~$1.5M market cap, AI robotics pivot with fresh revenue catalyst. AIIO playbook.
Twist Bioscience Corporation Agreed to Settle $17 million With Investors over product quality, manufacturing issues, and misleading margins
Missed the Chips/Memory rally? Buy the DNA: $TEM
Bio-Digital Defense: FY 2026 NDAA Catalyst for $AVAV, $BBAI and $EBS
Twist Bioscience Corporation Agreed to Settle $17 million With Investors over product quality, manufacturing issues, and misleading margins
DRTS: Alpha Tau is gonna save lives and we're gonna make $$$
$OSRH bio penny gem with 20m Market cap and $815m pending License deal with Definitive Agreement due by April 30
$OSRH biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30
OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$MAJI Made announcement: 3 acquisitions to be signed over 2 weeks.
$OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$OSRH tiny deSPAC biotech penny with 20m Marketcap and $815m pending License deal with Definitive Agreement due by April 30 (crazy undervalued!)
$QSI news of a new MEASUREMENT LAYER IN CANCER/ONCOLOGY research that no other commercial device in the same field could do is kind of insane. It went from 0.79c to over 1 in a day and it is still UNDERVALUED.
$QSI Quantum-SI JUST BROKE THE DOLLAR MARK ON ITS INCREDIBLE CUSTOMER NEWS AT THE UPCOMING AACR CONFERENCE IN 2 DAYS! (PTM/New cancer detection method/VARIANT VALIDATION).
$QSI Quantum-Si just RIPPED 20 percent to $0.95 since my previous post and they just dropped new information AGAIN. Theyβve got 2 separate customer posters going live at the American Association of Cancer Research Annual Meeting 2026 in 2 days, and this isnβt fluff folks.
$QSI Quantum-Si (Incredibly undervalued at 0.85c close to all time low) just released a manuscript on being the FIRST OF ITS KIND in the proteomic field to identify new CANCER treatment strategies with them attending AACR in 2 days time. competitors HAVE not done this before on a proven level.
The 6G Play Youβre Too Regarded to See: Swedish Microcap Beammwave AB is Literally Writing the Future
PSTV: Still holds more than 5x upside potential from current levels.
Energy Investing Over 20 Years: I simulated $20k in Traditional Oil (XLE), Clean Energy (ICLN), and Midstream Pipelines (AMLP). Here is the data.
Why is Inovio Board investing in the Co. even as shares crash? It's a tell to a card player- A strong future movement is in the cards?
Can SoFi Management Be Trusted? Comparing Management Statements with Hard Data
You need to understand what is going on geopolitically
DD: SMCI's Co-Founder Got Arrested and I'm Just Sitting Here Holding PENG
$QSI BIGGEST CATALYST IN ITS ENTIRE HISTORY IS THIS YEAR 2026 AND IT IS INCREDIBLY UNDERVALUED at 0.88. A full overview of its insane flagship technology "Proteus" and recent expectations.
$PACB: A beaten down genomics stock with disruptive technology, increasing revenues, and very interesting partnerships (DD from someone who works with their tech regularly)
Got my DNA results, I've been retarded for 1000s of years.
$QSI MEGA insider purchases filed yesterday ahead of proteus technology trials reminiscent to that of Illumina DNA sequencing technologies
Interesting microcap diagnostic company I found while screening biotech this weekend
Could Early Cancer Detection Become One of the Biggest Healthcare Markets?
Why traders watch microcap biotech before major study updates
KULR Should Sell Its BTCs and Go All-In on AI Data Center Battery Infrastructure
Headline: A Chronological Audit of the 2009 Digital Archetype: 2026β2028 Energy Transitions [NOT AI - Metaphysical Decoding]
CXAI stock rebound from all time lows, retake 50$ in spirit of TCGL
GameStop is shooting to acquire π― Target Corporation π―
Taking a closer look at the Opendoor situation: Is it a turnaround or more of the same?
$SONM / $DNAX will become an AI infrastructure provider tomorrow
SLGB β Tiny Float Float Trap Setup That Could Ignite a Squeeze
Deep Dive. From Kits To Scale: How MYNZ Could Turn EU Traction and Quest Into A Real Business
Intellia, NTLA, highest shorted stock on Wall Street with breakthrough gene editing technology
My realtime thesis based on my tech career
What speculative sectors of today will lead to the next generation of bagholders/community members?
Amazon's Product DNA is Falling Behind in the AI Era
Amazon's Product DNA is Falling Behind in the AI Era
$ZCMD - The "Bottom-Fish" Setup of the Week. Why this $0.50 level is a loaded spring.
Shopify ($SHOP) isnβt a retail stock. Itβs a commerce operating system and that changes how it should be valued.
U.S. Path In Plain English: eAArly DETECT 2 Now, Pivotal Study Next
What Mainz Biomed Actually Sells Today (And How To Track It)
This is Europeβs secret weapon against Trump: it could burst his AI bubble
Who Pays In Germany Today: At-Home CRC Screening And Coverage
Screening Beats Late Chemo: Building A Watchlist Around Prevention
[Sen. Mark Warner: US wants more spying on Chinese Chinese] Is Biotech the new rivalry?
$MAJI PR Out - Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms
The U.S. Corridor Is Open: Why Noninvasive CRC Coverage Makes FDA Chatter Move Stocks
MCED Hype Helps, But Targeted Screens May Win First On Cost And Coverage
How An Asset-Light Model Can Scale Screening In 2026
Why A Microcap Can Pop On βSoftβ Headlines: The MYNZ Playbook In Numbers
Global Stage, Tiny Cap: Why MEDICA 2025 Exposure Could Matter For Mainz Biomed
$CAI DD: Precision medicine could've saved Nana (113% YoY Revenue Growth)
MYNZ: Tiny Early-Detection Name That Can Reprice Fast If 2025 Data Delivers
Small Stock, Huge Potential: Why This Diagnostics Play Is Heating Up
A Real Alternative To Cologuard Or Just Talk? How To Judge MYNZ Without Hype
Mainz Biomed (ΠYNZ) Deep Dive: Product, Execution, Todayβs PR, And The Trading Setup
Commercialization Lens: Why A Regional Gastro Meeting Can Still Matter For MYNZ
$INO - THE DD. BLA SUBMITTED. SHORTS ARE TRAPPED. CATALYST TOMORROW. πππ
under the radar potential gene editing powerhouse: Precision Biosciences
PACB β The sleeper biotech that could catch fire soon
AMZN IS A $4 TRILLION STOCK AND THE MARKET IS SLEEPING
Dominating Holdings $DOMH - Micro Float Trump ties and perhaps backbone of the X everything app partnership infrastructure
Genenta (GNTA) going crazy pre-market (+300%)
Good evening everyone. Here is why I'm excited about Aprea Therapeutics (APRE) before tomorrow's catalyst.
Telomir Pharmaceuticals Unveils Preclinical Data Showing Telomir β 1 Outperforms Rapamycin and Chemo in Prostate Cancer Model
YOLO: CLOV $4Cs β BYND ran, now itβs health stock season
All synthetic biology companies that use native yeast like BYND, DNA, Impossible Foods are doomed to fail. Ride the wave and GTFO. Source: I lost 60k in synbio a few years ago.
So Upwork has a PE ratio of Ten>>? If u missed google at a low pe your going to want to buy this one! Same case scenario? Well not really!
MYNZ In One Read: Whatβs Real, Whatβs Next, And How Iβd Frame It Without My Opinion
MYNZ In One Read: EU/UAE Commercial Footprint, Insurer Angle, U.S. Path, And A Balanced Take For Traders And Investors
The market is laughing at a βpenny stockβ that might secretly be a $5B AI RTO in disguise ($SONM)
QSI β quietly turning into a legit growth story
Mentions
By culture and DNA you mean swastikas and child porn?
Saw a segment on FoxBusiness the other day about founder-lead companies are leading the gains currently. But then youβve got Apple without Steve Jobs. After he left in 1985, Apple went to crap; he came back and revitalized it and made sure it would continue to do so. I guess it fully depends on how much Elon puts into the culture and DNA of his companies that they continue to perform without him.
Preferably two to make sure the DNA is passed on.
We donβt even know how to keep people shielded from radiation in open space, and mars doesnβt have an atmosphere. Those colonistsβ DNA would be getting sliced into confetti by cosmic rays lolΒ
Elon never lost his mind. He had great PR and then fired them because he felt like PR didnt matter anymore. He is a silver spoon son of an apartheid emerald mine investor. His maternal grandparents moved from Canada to South Africa because they liked apartheid. His dad groomed and impregnated his drag addict step daughter. This is the environment He comes from. The guys pushing great replacement stuff and and having a chatbot that undresses minors has this all in his DNA. He didnt lose his mind.
Allright folks, I know a lot of you are getting jittery and nervous given how much this keeps dragging out. I just want to remind everyone that what Chardan appear to be doing here is borderline some of the greatest financial engineering you will ever see - they are spinning so many plates and everything must be de-risked to the Nth degree in order to execute this properly. As we all know, we've had a few recent developments: \- SONM received NASDAQ delisting notice on 22nd May \- SONM cancelled the ChEF \- SONM announced a pivot into decentralised AI \- Qumulus filed an unexpected 6th amendment to their S1 So what the hell is going on? Let's start with Qumulus and the direct listing. Some highlights from their most recent S1-A: \- ATW facility doubled to $90 million \- New co-location facility in Denver, Colorado \- $124 million in secured contracts \- Q1 financial statements prepared Now I can already hear the wheels spinning in your head: if they have secured contract pre-payments and a $90 million facility, do they really need a public vehicle? Can't they just proceed with direct listing? Theoretically the answer is yes - IF everyone involved in this transaction hates money. Yes they have the $90 million and some prepayments, but this is a drop in the water when compared vs their 2026 business plan of 23k B300s, which would require roughly $1 billion. It's worth noting that the [USD.AI](http://USD.AI) facility they signed up to last October has now been completed tapped. Because they have had zero cash the last 8 months, they've not been able to find the 30% they needed for the deposit, and they've only been able to use $20 million of the facility and everyone else has jumped in front of them and signed $550 million in term sheets even though [usd.ai](http://usd.ai) only has $350 million or so in deposits. So Qumulus are even more fucked than they were 3 months ago because the entire facility is gone until [usd.ai](http://usd.ai) find more depositors. Meaning they need a reverse merger vehicle more than ever. The $90 million from ATW & pre-payments gives them enough to buy roughly another 2k GPUs - a drop in the ocean. Other reasons they won't direct list: Firstly, if they were to proceed with the direct listing, it would mean the company cannot raise money via capital markets for 1 year. A one year delay in raising capital = 1 year delay in execution, meaning 1 year's worth of lost contracts, which could be in the billions. It ain't happening. Secondly, direct listing means anyone with more than 10% is locked in and cannot sell. Guess who has more than 10% of the company? The two founders. If a direct listing happened, the two founders would be left holding the bag. Don't believe me? Look at the last 18 direct listings since end of 2024. The majority of those companies are either 80% down, trading under $1 or have delisted. Direct listings are liquidity events. Qumulus need capital. Thirdly, ATW are Chardan's sister company - they share a co-founder. They are financially motivated to maximise Qumulus' share price. Fourthly, the legal opinion of Fox Rothschild - Qumulus' lawyers - remains absent. It is the only missing exhibit from the most recent S1-A. If Qumulus was genuinely going for a direct listing, why leave out the legal opinion to be filed later down the line, which would mean another round of SEC review and further delay? Take a look at any other direct listing on edgar from the last 18 months - the legal opinion either appears in the original S1 or within 1 or 2 amendments. We are six amendments in and the legal opinion is missing. Why? Because the legal opinion will be different for a reverse merger. Let's move on to SONM. Hindsight is beautiful thing. Admittedly I have not predicted everything perfectly and I don't have a crystal ball. But what I have realised with every filing/event is that things make more and more sense with the benefit of hindsight. I strongly believe the NASDAQ delisting warning was manufactured as a catalyst by Chardan (not that it needed much manufacturing). By manufacturing, I mean delaying the transaction long enough such that an external event - nasdaq's delisting threat - necessitated the transaction. This event provides SONM with the perfect cover to complete the transaction without the accusation that the merger was pre-planned. No SEC lawyer will ever successfully argue that a publicly listed company manufactured its own delisting threat - it would sound utterly ridiculous to any judge. Something similar happened with Movano/Corvex: within 1 week of the NASDAQ delisting warning, they signed an LOI to explore a reverse merger, which completed a few weeks later. The ChEF cancellation was expected - you cannot sign a merger deal while an offering of shares is valid that the merger counter-party has no veto on. This is exactly what happened again in the case of Corvex/Movano. Their S1 says: "We will not sell any Purchase Shares to Chardan without the prior written consent of Corvex (as defined below) prior to the closing of the Merger" Additionally, Chardan cannot have an active ChEF with SONM while advising Qumulus on the merger because there would be a conflict of interest. This was also the case again with Corvex/Movano: "the draft term sheet delivered on June 7, 2025 reflected the partiesβ understanding that Chardan had been acting as advisor to each of Rorschach and Sonnet, and that **Chardan intended to resign from the latter engagement** with respect to the Transactions prior to execution of the term sheet. The draft term sheet also anticipated that Sonnet would **reengage Chardan as its advisor with respect to any financing in support of the Transactions**," So the ChEF cancellation had to happen, and it will re-appear in the merger S1 prospectus once the 8k is filed. Now let's talk timelines. We have a hard deadline of 26th September because this is the "public listing date" set out in the ATW convertible note. If Qumulus is not public by then, ATW liquidates Qumulus. They have a gun to their head. And that gun is the direct listing itself - remember what I said about the founders? Now, realistically there is an even sooner deadline: mid-August. There are three converging events pointing to this date: 1) SONM AGM - must be within 13 months of last AGM, which was 18 July last year 2) SONM Q2 results - due 15th August, another quarter of no revenue = death sentence 3) Qumulus Q1 statements - these go stale on 13th August All this means that a shareholder vote must be held by 13th August at the latest. Working backwards, shareholders must have at least 20 days' warning of the vote, and the SEC must have at least 10 days to review the proxy. This puts us at an announcement by Monday 13th July at the absolute latest. However, it leaves no headroom if the SEC has further comments on the prospectus (theoretically it should not if the S1 has been completely derisked & fully reviewed via the direct listing process). It also does not account for the fact that the NASDAQ hearing must likely happen before then. About the NASDAQ hearing panel. If the plan SONM are presenting to Nasdaq is a transformative merger, they need to have 'pro forma' financials that are not stale. Pro forma = as if. In other words, what the financials of the combined company would look like. So in this sense, the Q1 financials we saw this week in the most recent Qumulus S1-A were mandatory, and they are doing well to again get these reviewed by the SEC before the panel happens. All this to say: everything is pointing towards an announcement around end of June/beginning of July. This also coincides with 3 other things we know: 1) The now defunct put option, which had an expiry date of 30 June 2) The QumulusAI roadmap - according to their own tweets, GPU deployment ramps to 9k GPUs in Q3 3) The IXP deployment plan - which begins [by July ](https://www.qumulusai.com/articles/moonshot-and-qumulusai-announce-strategic-agreement-with-connected-nation-internet-exchange-points-to-deploy-a-nationally-distributed-ai-compute-and-internet-exchange-platform)latest according to their own press release I'm not going to sit and pretend like I haven't given 5 or 6 wrong predictions on dates before. But in hindsight, it's easy to see why I was wrong. Someone mentioned earlier in the comments that this path was supposed to be faster and if anything it has been slower. And yes, I was wrong to think they went about it this way because it would be faster. They went about it this way because it was the only way they could do it, and that has meant waiting and putting on a show for the regulators. I should say here that Chardan do not appear to be doing anything illegal by engineering things this way. They just appear to be bending the rules of what is allowed. One final note. I too have wondered if there are other public vehicles that they could pivot to and my search yielded nothing. I screened over 4,000 NASDAQ companies with the following criteria: 1) Under $100 million market cap 2) Trading over $1 dollar 3) US-based (important if they want to chase government contracts, which they do) 4) Under 5 million outstanding shares This screening yielded some 63 companies out of the 4,000+ listed. I then looked at all 63 companies more closely - press releases, filings, financial advisors, the works. None of the companies presented links as strong as SONM, and the few possible candidates (roughly 5) either had issues with their corporate governance, share structure or just bad finances. It's SONM or bust for Qumulus. And bust would be a direct listing. Let's see if everyone involved here - Chardan, Qumulus, SONM, DNA & ATW - hates money. I'm betting on everyone's self interest.
Technically, it's called a DNA Packet.
Key Ingredients Banned in Europe but Allowed in the U.S. Got to give credit to Europe, atleast they ban some of the chemicals they allow here Titanium Dioxide (E171): A whitening agent commonly used in candy, salad dressings, and coffee creamers. It was banned in the EU due to concerns over its ability to accumulate in the body and potentially cause DNA damage. Potassium Bromate (E924): A dough strengthener and whitener used to make industrial bread and baked goods. Banned in the EU, Canada, and Brazil due to links to cancer and kidney issues.BHA and BHT: Common chemical preservatives used in mass-produced cereals, cake mixes, and corn chips to extend shelf life. Both are severely restricted in the EU. Propylparaben (E217): An antimicrobial preservative used to lengthen the shelf life of packaged baked goods and tortillas. It was banned in the EU due to potential endocrine disruption and reproductive toxicity. Ractopamine: A growth-promoting drug given to farm animals in the U.S. to increase leanness. It is banned in over 160 countries, including all of Europe and China, due to health concerns in both humans and animals.
If I keep options running on this account the only thing I'm really interested in is buying LEAPs on longshots I really like. CRSP, DNA, ACHR, RIVN and a couple others. Farming some premiums with the theta gang is also very tempting.
He was a financial executive of ginkgo bioworks $DNA -98% stock price, and a financial executive of Astra $ASTR (now delisted to avoid bankruptcy) which was also similarily -99% or so. So his last two companies he worked at in an executive financial role basically lost the entire value of the company
DNA is only 16.61 kb? If so then when will reddit offer us fanboys an IPO that we can profit from. Or should we Gamestonk pump and dump elons pet funding project.
The mental illness in this thread is palpable. It's like you think life IA an anime or something. 0s in your bank account does not change your DNA ya psychos.
Itβs a long way from being on par because of cost. If it were cheaper there would never be a reason to use short reads. So if you think PacBio will take market share it mostly comes down to the Revio 2 outperforming the next Illumina instrument on cost, which is possible but highly unlikely based on past improvement rates and the fact that Illumina can drop consumable costs until PacBio goes bankrupt if it has to. Comparing BioNano is entirely fair as an example of a company in the biotech instruments space that investors had high hopes in, with a proven and unique technology related to genomics, that essentially failed without getting bought up. Itβs irrelevant to my point that itβs not DNA sequencing. Itβs more likely that long reads wonβt take market share at this point. Look at the revenue trends in the past 5 years. Also consider how sequencing is being used increasingly for single cell RNA-seq which is almost fully dominated by Illumina because long reads give almost no advantage there. I work in this field and Iβm invested in PacBio and ONT so Iβm not talking out of my ass. At the moment I think itβs hard to deny that the future is not bright for long reads, even if they stay around as a niche product for genome assembly.
New York Time Scientists have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics. TLDR: Alcoholism, propensity for gambling, and regard genes are being edited out for the next generation. Calls.
What do you mean a long way away from being on par with short reads? Itβs already better in some regards, the main limitation really being cost which is being actively reduced and also throughput perhaps. Comparing BioNano to long read sequencing is not a fair comparison. BioNanoβs tech operates in a tiny niche of a niche, itβs not even classified as DNA sequencing and isnβt comparable to dna sequencing companies really. Obviously PacBio isnβt going to overtake Illumina any time soon or perhaps ever. It doesnβt mean PacBio canβt grow significantly. Long reads sequencing will continue take market share as costs reduce because there are limitations that short will never overcome.
Porsche is a German automotive manufacturer renowned for producing high-performance sports cars, SUVs, and sedans. The brand is synonymous with a unique blend of racing heritage, engineering excellence, and everyday usability. History and Foundation The company's story begins with its founder, Ferdinand Porsche, a brilliant engineer who had a significant impact on the automotive world. Before founding his own company, he worked for other prominent manufacturers, including Daimler. One of his most famous early projects was designing the Volkswagen Beetle for the German government. In 1931, Ferdinand Porsche established "Dr. Ing. h.c. F. Porsche GmbH" in Stuttgart, Germany. Initially, the company focused on design and consulting work, but it was his son, Ferdinand "Ferry" Porsche, who would build the first car to bear the Porsche name. * The Porsche 356 (1948): This was the first official Porsche sports car. It was lightweight, agile, and featured an air-cooled, rear-engine design, which became a signature for the brand. The 356 laid the groundwork for Porsche's future success in the sports car market. * The Porsche 911 (1964): Designed by Ferdinand "Butzi" Porsche, Ferdinand's grandson, the 911 is arguably the most iconic and recognizable sports car ever made. With its distinctive design and rear-engine layout, the 911 has been in continuous production for decades, evolving through numerous generations while maintaining its core identity. Key Models and Innovations While the 911 remains the brand's flagship, Porsche has expanded its lineup over the years to include a diverse range of vehicles, each carrying the brand's DNA of performance and precision. * 911 Turbo: A high-performance variant of the 911, known for its incredible speed and turbocharged power. * Boxster and Cayman: Mid-engined sports cars that offer exceptional handling and balance. The Boxster is a roadster, while the Cayman is a coupe. * Transaxle Cars (924, 944, 928): In the 1970s and 80s, Porsche introduced front-engine, rear-transaxle models like the 944 and 928, which were praised for their balanced handling and offered a different driving experience. * Cayenne and Macan: The Cayenne, a luxury SUV introduced in 2002, was a significant departure for the brand but became one of its best-selling models, establishing the high-performance SUV as a legitimate segment. The Macan is a smaller, compact luxury SUV. * Panamera: A four-door luxury sedan that brings sports car performance to a more practical format. * Taycan: Porsche's first all-electric sports car, the Taycan demonstrates the brand's commitment to innovation and high-performance electric vehicles. Racing Heritage Porsche's identity is deeply intertwined with motorsports. The brand has a legendary history in racing, with an estimated 24,000 race wins around the world. Porsche has achieved remarkable success at the 24 Hours of Le Mans, the most prestigious endurance race in the world, with over 50 class wins and a record number of overall victories. The 917 race car, which won Le Mans in 1970 and 1971, is one of the most legendary race cars in history. This racing DNA is a core component of every Porsche, influencing the design and engineering of its road cars. #foryoupageβ€οΈβ€οΈ #foryou #for
>2023β2026: βAI will change the world.β >2027β2035: βHave you updated your DNA yet?β Wait next year they're just gonna jump to gene editing before AI delivers on all these promises? Will they then just jump to something new in 2036 before I get my gene editing?
I don't believe that is accurate. Might want to wait until after the mid-June Falcon 9 launch π or research the myriad of other hand Rocket companies bit more. I pondered shorting ASST but after receiving some valuable intel, Im considering Calls. I possibly know someone on the inside that I may have shared DNA with (allegedly of course) explain to me last night the current situation going forward. ASTS SpaceMobile is preparing it's mid-June SpaceX Falcon 9 launch, with BlueBirds payload satellites 8, 9, and 10. The status of the satellites is as follows: BlueBirds 8 and 10 have officially arrived at Cape Canaveral, FL. BlueBird 9 has been dispatched from the Texas production facility and is en route to Florida to join the 8 & 9 for payload processing. Launch provider: SpaceX Falcon 9 Timeline: Scheduled mid-June at Cape Canaveral, FL *(Following the standard 3-to-4 week integration window with SpaceX)
his DNA was infused with a trading algo code
DNA is a biotech platform for AI
I just looked that up⦠and wow. I hate to looks shame anyone⦠but, I would not be surprised to see draconian-human hybrid DNA in that 23 and me.
Mine is CRSP. I keep it mainly because it is a huge scientific history and I want to be a part of it. It is a sequence of DNA that allows for gene editing. And I believe that, using this technology, some amazing medical breakthrough will be achieved.
Maybe if you combine their DNA it will create a child that buys low and sells high
DNA storage systems, using dna to store information
There's no decision to delist them. NASDAQ issues these "decisions" every day but gives companies the opportunity to present a "plan". The 8-k clearly says SONM intend to request a hearing and present a plan. The plan doesn't have to be actioned. They just have to show that they've got a plan. The NASDAQ doesn't want to delist companies and destroy shareholder value willy-nilly. All that said, I DO believe the merger will close before the hearing. That in itself is the plan. And the convertible note from DNA holdings is enough in any case to bridge the gap if the merger needs more time. As is the ChEF if they need it. They've got options. Qumulus won't give a fuck about this delisting notice. The nasdaq is not going to delist a $2 billion dollar company.
23andMe is flawedΒ It will not test for ancient Hebrew DNA
Tons of those Spacs boomed eventually. I held a few and the roller coaster was wild. Everyone tried to crush my soul. Wins: rklb, pl, draftkings and total loses like DNA.
Im a Network Solutions Architect and Iβve focused on Juniper solutions for almost 20 years. Their MIST platform is really good for enterprise networks. APSTRA for Data Centers is also good. Price increases and supply chain constraints starting last year have caused orders to be delayed. Currently there is a 200ish day lead time on switching hardware for example. This has caused a lot of deals that were in flight which would normally have closed in Q4 to slip until Q1. Cisco has required DNA license pricing even if you donβt use the features which is really frustrating a lot of customers and they are pricing themselves out of a lot of business right now. Juniper (now HPE) has been taking market share from Cisco with their new cloud based AI solutions and aggressiveness on price.
You cannot convince me he doesnβt have 25+% Neanderthal DNA
How did multiple donor semen from different DNA donors get into his mom?Β
Yeah it wonβt work. Facebook is about social circles, your neighbours, your family, etc. Forums will end up being locally significant due to this, garage sales, local swaps/meetups, block parties/groups and of course nosy neighbourhood watch coordination. People on Reddit organize around topics not locality/social circles. Meta has been trying to do the everything app and in my opinion failing primarily due to not understanding their own ecosystem and user population. It screams desperation. Meta ima give you one for free: buy that failing DNA test company and connect people to lost/distant family members. Create groups for families to organize then layer in financial and social services. Example; Let families donate to a group fund. People on your platform are desperate to virtu single, so let them. Give them a gold star for being a βgood family memberβ when they donate to the group funds. Creating inter and intra family group engagement. Everyone on instagram is either a βevent organizerβ or βentrepreneurβ so put them to work. Group funds from families looking for social interaction in a decaying society can be used by vapid βget the bagβ grifters who pretend to do social work. Take your 10% and sit on buckets of cash. Your users too poor? Offer debt! Micro loans, βfamily paymentβ plans, and buy now pay later schemes so everyone can suffer together! Wedge yourself further between natural human interaction and extract βshare holder valueβ. People will suffer but your stock price will grow!
It speaks to acting on facts rather than emotion. Do I want people to die? No. Am I realistic in the fact that war is part of human nature since the beginning of time? Yes. War is inevitable and in our DNA. I'm realistic.
There's so much DNA in these undies I think it'll confuse the cops and I'll be ok
Mulica has finally updated his LinkedIn to reveal his board seat at Qumulus. It indeed confirms that he joined the Qumulus board in August last year: [https://imgur.com/a/ehywXfg](https://imgur.com/a/ehywXfg) He's also replaced the SONM section with DNAX info. Of particular interest is the following line: "DNA X is built to serve as a bridge for institutional digital asset management, backed by public market corporate governance"
Massive rally on TWST stock today at 10%, I wonder what theyre cooking (beyond synthetic DNA and Amazon deal)?
DaRT is a physics based treatment, not biological. Essentially proprietary seeds that emit alpha radiation to destroy DNA with a small kill one to avoid healthy tissue exposure. 100% glioblastoma tumour regression in 2/3 patients with no reoccurrence in three months, which is unheard of. Literally, nothing else has done that. Trial data is available for skin cancer treatment and is overwhelmingly positive, 89% complete lesion response, 77% 2 year recurrence-free survival in 81 head and neck tumours. Side effects are minimal. As a physics based treatment, its tumour agnostic. Brachytherapy is already commonly used. DaRTs would be the new payload and placement is using Alpha Tau's dosimetry protocol. This isn't a pump and dump. It is mechanistically sound. DaRTs are also a medical device, not a drug which has significantly different approval streams.
Loremaster here: yes. He's the founder of the company. Originally almost every high level exec in AMD/Intel/Nvidia worked at Fairchild Semiconductor. It was owned by a different company, who looked at semi conductors as a side hussle. People that left: **Intel**: In 1968, Robert Noyce and Gordon Moore **AMD**: Just a year later in 1969, Jerry Sanders (with 7 others) **NVIDIA**: While NVIDIA was founded much later (1993), its DNA traces directly back to this lineage. Co-founder Jensen Huang worked as a microprocessor designer at **AMD** This is probably the biggest fucking fumble in the history of mankind.
How can I buy shares in a future Wemby sperm company? Who gives a fuck about spaceships, that manβs DNA will advance the species much further.
The put option has been terminated, which was almost certainly a condition of completing the merger. Chardan/Qumulus/ATW would under no terms agree to closing a PIPE while a put option exists that could strip DNAX away and trigger an event of default under the previous DNA Holdings note. Other than that, the 10-q is largely a nothing burger. The press release, however, is far more interesting. "AI" is mentioned 10 times (and more importantly, for the first time) as part of the company's go-forward strategy. The phrase "decentralised AI" is also used (qumulus AI's business plan). It is clear to me that this language is being used to bridge the company between what it is today and what it will eventually become. It is difficult to say exactly when this will complete. The ATW note demands this is all sorted out by September. Concurrently, SONM is unlikely to survive the next 10-Q (due mid August), as it would have to report zero revenue again. My hope is that the transaction closes in June. However, it would not surprise me if we see another S1-A with Q1 financials, which could drag things out to July. At this point, all the housekeeping appears to be done. Any more S1-As to my mind would surely be overkill, but every filing has proven to make sense in retrospect, so who knows.
The put option has been terminated, which was almost certainly a condition of completing the merger. Chardan/Qumulus/ATW would not agree to closing a PIPE while a put option exists that could strip DNAX away and trigger an event of default under the previous DNA Holdings note. The [press release](https://www.newsfilecorp.com/release/298202/DNA-X-Inc.-Reports-First-Quarter-2026-Financial-Results) also makes reference to AI a total of 10 times, including "decentralised AI" (qumulusAI's business model). This is the first time the company has made reference to AI as part of its go-forward strategy, and is almost certainly using this language to bridge the company between what it is now and what it will eventually become. It's hard to say when exactly now this transaction will close, but certainly DNA cannot survive another 10-Q showing zero revenue. They were able to get away with it this time because in Q1 DNAX was not consolidated, so revenue appeared as "other income".
Impossible to be riding this out until EOY 2026 because the ATW note demands that Qumulus go public by 26 september - if they don't, ATW can liquidate qumulusai as they have a first priority lien on their assets. Overall, the 10-q was a bit of a nothing burger. Turns out the equity transaction referred tobeing pursued was the new DNA convertible note. The biggest reveal to me is the press release, which not only refers to AI for the first time but mentions it a total of 10 times. It also includes the phrase "decentralised AI": "Having successfully completed a strategic exit from our legacy business, management has made a **deterministic decision** to reallocate our resources into the high-growth, h**igh-margin decentralized AI** and crypto trading sectors" Decentralised AI is the entire QumulusAI business model. This press release creates the bridge between what SONM/DNAX is and what it will become. Question is how long. Hopefully this still closes in June but I won't be surprised if this drags out to July or even early August.
8k and 10q today - overall seems like good news, but looks like we could be riding this out through the end of 2026 now due to the new DNA Holdings note that doesnt mature until Dec 31
Co-Diagnostics, Inc. The Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
DNA certified - how did PSA verify that π
DNA certified?? Bro got his fluids on it??
Its alittle confusing, isn't it? Like we got "DNA studies" and then majority of America is supposed to be Christian, yet we do the opposite of Bible teaching and we cut lines in the Bible to fit narratives
A DNA certified bite. Easily adds 20% to the value.
DNA certified eh.....what sample did they use?
Do I even ask what type of DNA was certified and how? π
DNA Certified? Does that mean you and Bane can, like, take out the Gotham Stock Exchange?
Powell DNA has a uniquely warm and creamy taste
DNA certified? Did he cum on it? Did Kash run it through the database?
DNA certified? So we can clone him in the future?
DNA certified. Did you cut him and make him bleed? or shear his scalp?
>but sadly I was still a sperm cell :/ Sperm is just a fertilizer with half of DNA, you were never a sperm. The EGG is the cell that grows into a baby. Also sperm is produced constantly and dies after few days but a woman is born with all her eggs.. you were still an unfertilized EGG cell. I wonder why people ALWAYS try to pretend we came from a sperm entirely and ignore the egg even though technically we were mostly the EGG
RIP Joe Rogan. He tried to fight an AI because he has violence in his DNA.
Chemical synthesis at that scale uses up pretty much the entire worldβs SPOS capability to produce template DNA, and a huge amount of solvents, which are obviously bad for the environment. Biosynthesis using specific ligase enzymes will eventually reduce the necessity for chemical synthesis, but currently can only produce small amounts of sequence.
I see you are mad I called you out for using AI. AI agrees its AI generated AI-Generated Probability Rating: 95% βThis post is almost certainly AI-generated. While the economic concepts are sound and the analysis is sophisticated, the structural DNA, phrasing, and stylistic choices scream Large Language Model (LLM). The prose contains several linguistic idioms that AI models love to overuse when trying to sound authoritative yet punchy: β"This is arithmetic, not politics." (A classic LLM phrase used to sound objective). β"...is a rearview mirror with half the glass painted over." (A textbook LLM metaphorβvivid, clean, and a bit clinical). β"The thesis is not that everything is terrible. It is that..." (Classic AI syntax used to clarify intent). βConclusion βThe post reads exactly like a response to a prompt such as: "Write a comprehensive, deeply analytical Reddit post arguing why the April 2026 unemployment rate is misleading. Use specific FRED codes, analyze the gig economy, and include balanced disclaimers for disputed data."
Synthetic Biology is going to absolutely melt brains this decade. While everyone is still fighting over the last scrap of AI chips, Ginkgo Bioworks ($DNA) is basically trying to compile code for living organisms. Itβs either going to $0 or it's going to fund my retirement on Mars. No in-between. Obligatory: ππ Sir, this is a Wendyβs.
Most of the consumer DNA companies use microarray. Which Illumina also makes. They're one of two big suppliers (I work for the other one). Illumina isn't the only name in sequencing, but they're a top choice. Some platforms are better in specific ways, faster cheaper longer etc, but Illumina is competitive on all that and right in the sweet spot for normal use. Sequencing is a picks and shovels play with increasing demand from NIPT and cancer detection / treatment. I like my biotech bets with a little more YOLO but I think Illumina is solid. My theory on why they're in China is that lifting their restrictions would be an easy concession to the US. They aren't really a threat, China just made an example of them because they could, and as others have mentioned, Illumina did start that fight and deserved the payback.
Illumina makes and sells NGS machines, they are more advanced DNA reading machines that only one or two other companies are currently competing in. NGS and sequencing in general is a root of most current drug development involving synthetic biology, similar to how ASMLβs lithograph machine is for chip manufacturing. The only difference is that NGS machines arenβt that expensive and older sequencing machines can get the job done too just slower so Illumina still faces stiff competition even though only a few other companies sell similar machine for DNA sequencing. China has a huge biotech/pharma discovery industry so getting your machine into the market makes sense
It actually wasnβt that straightforward, illumina won some cases while MGI won others. Most notably MGI won a case against illuminaβs 2 channel sequencing that awarded MGI $334 mil. This basically forced both companies to settle and cross license their patents but overall hurt Illumina more since they can no longer dominate the market. Biosecure act was a dumb decision by Illumina to get themselves banned from China, one of the fastest growing market for DNA sequencers. Now Iβm guessing Illumina trying to unblacklist themselves which could be hard since MGI is tied closely to the PRC.
Honestly if u want to retire earlier continue to get your income up by 1. working a 9 to 5/do a rideshare gig, 2. Learn how to do Options(Im personally a fan of LEAPS), but make sure you know what your doing instead of attempting to throw your money in any stock thats going up, u should learn candles and market structure and also watch youtube videos on how to learn about options so that u can understand the basics 3. Continue investing, but be diverse and if u feel comfortable start getting more aggressive(look into future stocks that would run possibly after semiconductors like Quantum Computing, Photonics, & DNA computing) since youβre so young.
Illumina already had that play. They were the technology behind 23andme and ancestry DNA kits. Grow was crazy back then 2016-2019 then that market dried up. I'd guess China wants to sequence all of their citizens and the only company capable of that is illumina. Which would be massive. I worked at Thermo Fisher for a while and we had sequencing machines / kits we sold to China then it was discovered they were using them to sequence populations like the wiegers and a bunch of bad pr popped up and we pulled out of China for that stuff.y guess is China is like hey we need to do that still and illumina could help.
Just to provide some context from a person in the Biotech sector with a PhD. Illumina is basically the founding company of next generation sequencing, they created all the tech that's used for rapid DNA sequencing. They've also created many more products since then to investigate other relevant biological (transcriptomics, proteomics, etc.). Almost every company and academic institution in the US that performa biological research uses their machines and reagents at some point in their research.
We fought an entire war over taxes and some things will never leave our DNA as Americans π€£
DRTS - complete glioblastoma tumour shrinkage in 2/3 patients, 30% in 1/3 of a safety analysis group with no recurrence in 2-4 months which is ground breaking. Uses alpha radiation emitting DaRTs inserted via a catheter like deliver system into a tumour which obliterate DNA. Physics based so tumour agnostic. Approved for use in Japan for treatment resistant melanoma. Presenting their findings with pancreatic cancer at one of the largest oncology conferences in two weeks If the data continues to be this powerful, this is truly a cure for most cancers. Make money, save lives.
Robo feudal warlord era. Only shareholders will be entitled to command a platoon of droid militia to collect taxes and DNA samples for their overlord.
You said it like it is- Syncon antigen production method for designing DNA stimulated monoclonal antibodies is demonstrated to be the best magic bullet available. WHO has investigated the results of the coronavirus vaccine fabrication and when the next pandemic comes around Inovioβs patented vaccine technology will be first in line. This was demonstrated with a study replicating a bird flu vaccine from a computer model. This is the future of vaccine medicines.
$INO is the only public company with proven experience in hantavirus DNA vaccines. Studies against Hantaan, Puumala, and Andes strains are supported by the NIAID/U.S. Army.
I've been in this market for 24 years now, and if I had a dollar for every time someone predicted 'the big crash,' I wouldn't even need to trade anymore. Bubbles and crises are part of the gameβs DNA. They happen, but nobody,literally nobody,can time them with precsion. Most of these predictions just serve to spread anxiety while the rest of us are busy building.
Owned/traded Sony since the post dot-com days. The only benefit I got was when SFGI spun of and got free shares. The company is one of the remaining few conglomerates that would benefit from further split up. (They sold off their VAIO long time ago and recently BRAVIA). But they make everything from cell analysers to AI analytics and lacks focus - party of their corporate DNA. Playstation alone could compete with Netflix/Spotify.
Twist Bioscience surged during COVID, they dominate in DNA manufacturing for genetic profiling of viruses (among other applications)
So your telling me they finally made the technology that Theranos was hocking, but BLLN got it right. "The underlying technology can quantify any DNA signal in blood which means the roadmap extends way beyond prenatal into oncology, rare disease, pharmacogenomics, MRD monitoring, and potentially infectious disease."
Trump has cockroach DNA that allows him to survive while making those around him very annoyed π
So I was watching an old Ancient Aliens episode the other day because I wanted to be reassured that the answer to everything is "aliens did it". Anyway, they were talking about storing data in synthetic DNA. I did some research and it is a real thing. TWST and ILMN are the tickers that are pure plays. I am up 5% since I bought them on Friday. I would be up more, but I started light and slowly bought more the last couple days.
Commented on DNA all weekend. It is up 10%. Toad you so
TWST earnings: Twist Bioscience delivered its 13th consecutive quarter of sequential growth, with Q2 revenue jumping 19% YoY to $110.7M and beating guidance. The companyβs core growth engine is fully operational: DNA Synthesis and Protein Solutions (DSPS) accelerated 28% YoY, buoyed by rising AI-driven drug discovery demand. Operational efficiency is improving, pushing gross margins to 51.6%. However, top-line success hasn't yet reached the bottom line. Net loss widened to $44.0M (from $39.3M a year ago), dragged down by a $7.2M litigation settlement charge and a 19% surge in SG&A expenses. Despite the cash burn, management raised full-year revenue guidance and firmly reiterated their target to achieve adjusted EBITDA breakeven by Q4 FY26.
You're focusing on the completely wrong part, the variability is what people are commenting on, not the percentage of your DNA is in the sperm. There's not a lot of variability on which egg you're gonna get at the time or conception, whereas millions of sperm could have influenced the outcome. The egg is much more determined by which month your parents decided to bang during than anything else so it just isn't worth commenting on when we're joking about who you could've been.
Ask for a DNA test and don't sign the birth certificate
Sperm is just a fertilizer with half of DNA, OP was never a sperm. I wonder why people ALWAYS try to pretend we came from a sperm entirely and ignore the egg even though we are mostly the EGG
On thing you cannot count on in the US is healthcare expenses . Insurance from the ACA, if it survives, is anything but cheap if you earn a decent wage. And healthcare costs is one of those things that is incredibly expensive. I have a medical condition that requiements me to get a colonoscopy every year and a MRI every year or 2. With a negotiated rate, the colonscopy is about $25,000 and the MRI is about $15,000. So right out of the bat, if I had to pay out of pocket, that's $40k/year. People say, well you can get it cheaper in mexico, thailand, taiwan etc etc. Well, if this s routine checkup, yes. But if this is a routine checkup, I wouldn't be doing this every year. Basically, I have a genetic condition that is guaranteed 100$ colon cancer, and doxtors found out about this when I was early 30ies. Before that I don't drink, dont' smoke, no drugs, and for the most part eat healthy no soda, no excessive sugary snacks, lots veggies, lots of white meat and fish, and red meat sparingly. Sorry, something caused your DNA to mutate because nobody else in familial ancestory or your sibling has it and you're considered a "spontatneous mutation". So basically while most people get their colonscopy in their 50ies and find many 1 or 2 polyps... Doctors found over 1000 polyps in my colon, which basically meant taking the entire thing out. Well I was lucky, because if you take the entire thing out, normally they create a little button for you in front and you get to wear a bag the rest of your life...For me, I had an option they take most of it out and leave the last 5 inches so I can more of less function the same way. But in doing so, that last 5 inches will continue to grow shit, but instead of 1000, it;'s more like 20-30/year. So every year I need to go see Mr. Assman, so he can go remove the 20-30 things that grow in there so they don't develop into cancer, which is guaranteed. Cost aside, it's just annoying as fuck to prep for a colonscopy, drinking that awful fluid, shitting the entire day, and then not being eat for 48 hours before and then after because they also need me to swallow a pill camera to check the rest of my GI track. You're not going to be able to do this at 1/4 the cost in mexico. And if you go to a country where there is universal coverage, you'll be waiting forever to find a specialist that does this, again it needs to be done every year. Here in the states, don't bother if you have a preexisting condition with getting on an HMO plan or with a high deductible HSA plan. And the you are left with a PPO plan which frankly doesn't matter if you pick the bronze, silver, gold, or platinum plan... The diffence between all 4 is the lower tier plan is you pay lower monthly premiums but have higher deductible and out of pocket costs...The platinum plan you pay higher monthly premium but lower out of pocket expenses...But if you do these special procedures, you're going to hit the maximum out of pocket expense anyway, so you end up paying about the same regardless of which plan you pick.. The monthly premimum and out of pocket expenses total about $15k/year or a $10/year saves versus without insurance and goes up with age. Yes, there is such a thing such as mediCal which is free medical coverage, but that only is a free option if you have close to nothing in your savings account, and then you are fully dependent on the social benefits of the US. MRIs, are not better. Simple procedure, but again around $15k out of pocket without insurance. Then let's talk about dental. Fortunately for me, my teeth are pretty decent. But some people dealt a shitty hand, like my GF, just has bad teeth. She brushes all the time, doesn't eat sugary shit, and yet still manages to get severe tooth decay. Dental is one of those things that royally suck in the US, even if you have insurance. Insurance while cheap, maybe $50/month covers very little, usually about $1000-2000 maximum coverage a year. Getting a filling these days cost a few hundred, getting a crown a thousand, and implants, let's not even talk about that. You can try to go to mexico and get it done, like she did , to save money, only for the dentist down their to royally botch things up and caused more damage that good, which is why she ended up needing to get about $20k worth of implants back here. I estimate that both me and my GF's healthcare burn rate is about $25k-40k/year (insurance premiums + copays + out of pocket expenses). There's insurance costs associated with my kid and her kids, but the assumption is when they grow up, they will have their own insurance. There was a period of time when I early retired from tech 4 years ago and that was pretty much my out of pocket healthcare costs for everyone. But as of last year, not that I really needed to work, I went back to work by invite of a CTO to work on AI, as a personal interest, and one of the side benefits (besides a pretty good paycheck that I really don't need, stock grants that are worthless right now) was pretty darn good PPO medical insurance where my total expense for myself and my kid is close less than $1000/year, leaving only my GF's dental costs of a few thousand. Huge huge savings by being on a company sponsored healthcare plan. It's expensive to get sick here in the US. It's even more expensive if you are born with a pre-existing condition. In fact, given everything that happened concerning my medical condition, the followup divorce from it, the detour I was forced to take when some asshole coworker stole my project while on medical leave....I seriously thought about doing the 180 degree reverse and driink heavily, smoke heavily, do drugs heavily, and eat high sugary snacks and food and totally fuck up my health since it couldn't be really fucked up any more and my health care costs to deal with it all would still be the same, lol.
DNA is a great (((risky))) buy opportunity. Could 2X this year
Went shopping last week. Bought RDDT pre earnings. META dip. DIS for their earnings. And DNA for a fun gamble.
DNA digital data storage. Look it up.
amd bers should not spread their DNA LMAOπ€
Oh believe me I also put money into risky stocks and have either done well or done terrible. Some of them I've just sold off and taken the loss for my taxes and others like apps, DNA and elf, I've decided to just keep and whatever happens happens. Apps and DNA were bought because of articles and some videos that said those were going to be the next huge stocks that blow up within the next couple of years. Oops!
Hear me out: DNA digital storage. Look it up.
In financials I'm big on ABX. Still extremely cheap here. I own a ton. JXN also decently cheap. I own, but it's not as exciting. KFS is technically a financial, but has a lot of other businesses going. In healthcare.... ALHC really has me interested, but I don't own it yet. They have a model of health insurance that actually tries to help it's most sick customers and thus lowers costs long term. CLPT and QURE are extremely cheap if their thesis plays out, but also early stage biotech is risky. So beware. TWST has gotten expensive, but is a great watchlist name. They make synthetic DNA for medical testing.
I'm not waiting 30 years for retirement. Wage slave is not in my DNA, and I control my own destiny.
I mean itβs quite clear that the mechanism of DNA allows for unlimited scaling bound only by physics and biomechanics maybe. But ultimately physics of our world. Reasoning is a purely mathematical process as is being attempted in computers. For example evolution would be more akin to a stochastic walk across all possible sets of code. One of those sets can achieve AGI just like evolution eventually came up with intelligent life. We are just saying that LLMs are not in the set that leads to AGI. Not that AGI is impossible. Could we be wrong? Yeah sure, but the evidence we have right now is not pointing in that direction.
YUGE earnings week coming up! Also, does anyone else find it interesting that that we get two sets of teeth in our lifetime? Like, how does that get programmed into our DNA??